The EMA is set to perform accelerated reviews of Gilead Sciences’ applications for its twice-yearly injectable for HIV ...

A study finds that poor sleep quality is strongly linked to severe PMS symptoms such as anger, anxiety, and fatigue in young ...

Higher TIL levels predict better survival in early ERBB2-positive breast cancer, supporting treatment de-escalation for select patients.

Discover findings that revealed that microbiota maturation in cystic fibrosis is delayed, preventing the establishment of a ...

A new study reveals that non-invasive biomarkers, including RDW, MPV, and appendix diameter, can help differentiate ...

Discover recent findings that indicate that c-Rel expression is upregulated in psoriatic skin lesions and decreases following ...

The FDA has cleared an Investigational New Drug Application for Zabalafin Hydrogel, a multi-target therapy for mild to ...

Discover recent findings that highlight the potential for urinary DNA methylation testing to improve early detection and diagnosis of bladder cancer.

Genetic risk scoring improves COPD detection beyond traditional methods, enabling earlier diagnosis and better patient ...

Disparities in standard-of-care, advanced, and same-day diagnostic services among patients with abnormal screening ...

NEW research has shown that pridopidine, a sigma-1 receptor agonist, does not exhibit a significant impact on the progression of amyotrophic lateral sclerosis (ALS) over a 24-week period.

Donor selection in T-cell-replete haploidentical donor peripheral blood stem cell transplantation. Leukemia. 2025;1-11.